The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder
- PMID: 16648320
- DOI: 10.1176/ajp.2006.163.5.805
The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder
Abstract
Objective: Light therapy and antidepressants have shown comparable efficacy in separate studies of seasonal affective disorder treatment, but few studies have directly compared the two treatments. This study compared the effectiveness of light therapy and an antidepressant within a single trial.
Method: This double-blind, randomized, controlled trial was conducted in four Canadian centers over three winter seasons. Patients met DSM-IV criteria for major depressive disorder with a seasonal (winter) pattern and had scores > or = 23 on the 24-item Hamilton Depression Rating Scale. After a baseline observation week, eligible patients were randomly assigned to 8 weeks of double-blind treatment with either 1) 10,000-lux light treatment and a placebo capsule, or 2) 100-lux light treatment (placebo light) and fluoxetine, 20 mg/day. Light treatment was applied for 30 minutes/day in the morning with a fluorescent white-light box; placebo light boxes used neutral density filters.
Results: A total of 96 patients were randomly assigned to a treatment condition. Intent-to-treat analysis showed overall improvement with time, with no differences between treatments. There were also no differences between the light and fluoxetine treatment groups in clinical response rates (67% for each group) or remission rates (50% and 54%, respectively). Post hoc testing found that light-treated patients had greater improvement at 1 week but not at other time points. Fluoxetine was associated with greater treatment-emergent adverse events (agitation, sleep disturbance, palpitations), but both treatments were generally well-tolerated with no differences in overall number of adverse effects.
Conclusions: Light treatment showed earlier response onset and lower rate of some adverse events relative to fluoxetine, but there were no other significant differences in outcome between light therapy and antidepressant medication. Although limited by lack of a double-placebo condition, this study supports the effectiveness and tolerability of both treatments for seasonal affective disorder and suggests that other clinical factors, including patient preference, should guide selection of first-line treatment.
Comment in
-
Light therapy and fluoxetine similarly effective for improving seasonal affective disorder.Evid Based Ment Health. 2007 Feb;10(1):26. doi: 10.1136/ebmh.10.1.26. Evid Based Ment Health. 2007. PMID: 17255395 No abstract available.
Similar articles
-
Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the Can-SAD study.Psychol Med. 2007 May;37(5):727-36. doi: 10.1017/S0033291706009378. Epub 2006 Nov 20. Psychol Med. 2007. PMID: 17112403 Clinical Trial.
-
Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder.Psychol Med. 1998 Jul;28(4):923-33. doi: 10.1017/s0033291798006813. Psychol Med. 1998. PMID: 9723147 Clinical Trial.
-
Second-generation antidepressants for seasonal affective disorder.Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008591. doi: 10.1002/14651858.CD008591.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2021 Mar 4;3:CD008591. doi: 10.1002/14651858.CD008591.pub3. PMID: 22161433 Updated. Review.
-
Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.JAMA Psychiatry. 2016 Jan;73(1):56-63. doi: 10.1001/jamapsychiatry.2015.2235. JAMA Psychiatry. 2016. PMID: 26580307 Clinical Trial.
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
Cited by
-
Bright Light Therapy for Major Depressive Disorder in Adolescent Outpatients: A Preliminary Study.Clocks Sleep. 2024 Jan 30;6(1):56-71. doi: 10.3390/clockssleep6010005. Clocks Sleep. 2024. PMID: 38390946 Free PMC article.
-
Light Therapy for Adolescent Depression: A Scoping Review.Curr Psychiatry Rep. 2023 Sep;25(9):373-386. doi: 10.1007/s11920-023-01437-5. Epub 2023 Jul 25. Curr Psychiatry Rep. 2023. PMID: 37490215 Review.
-
Can Rehabilitative Travel Mobility improve the Quality of Life of Seasonal Affective Disorder Tourists?Front Psychol. 2022 Sep 28;13:976590. doi: 10.3389/fpsyg.2022.976590. eCollection 2022. Front Psychol. 2022. PMID: 36248577 Free PMC article.
-
Detecting Critical Decision Points during Cognitive-Behavioral Therapy and Light Therapy for Winter Depression Nonremission and Recurrence.J Behav Cogn Ther. 2020 Dec;30(4):241-252. doi: 10.1016/j.jbct.2020.10.002. Epub 2020 Oct 29. J Behav Cogn Ther. 2020. PMID: 36186272 Free PMC article.
-
Vision-Related Quality of Life and Seasonal Affective Disorder in Patients with Glaucoma and Macular Degeneration.Vision (Basel). 2022 Jun 14;6(2):32. doi: 10.3390/vision6020032. Vision (Basel). 2022. PMID: 35737419 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous